New hope for young adults with CML: asciminib under Real-World scrutiny
NCT ID NCT07681258
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study looks at how well the drug asciminib works and how safe it is for young adults with chronic myeloid leukemia (CML) in the Gulf region. Researchers will collect information from medical records of about 80 people aged 18 and older who have taken asciminib. The main goal is to see how many achieve a major molecular response, a key sign that the leukemia is well controlled.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
asciminib
What this could lead to
If asciminib proves safe and effective in this younger population, it could offer a new treatment option for chronic myeloid leukemia.
What could go wrong
This is an observational study, not a controlled trial, so results may be less definitive. Side effects are possible, and the small sample size may limit generalizability.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- CASPALLO: Suicide Gene T Cells for Stem Cell Tra NCT00710892
- Real-World Bosutinib Use in CML: NCT05363488
- Cousin vs Sibling Donors for Stem Cell Transplan NCT07662382
- High-Risk Blood Cancer Trial with TMI and Transp NCT06802315
- Innate CD8+ T Cells and TKI Resistance in Leukem NCT04965649
- Stem Cell Transplant Study for Blood Cancers NCT05800210
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact